{{Rsnum
|rsid=7010162
|Gene=PRDM14
|Chromosome=8
|position=70064270
|Orientation=plus
|GMAF=0.3659
|Gene_s=PRDM14
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.9 | 52.2 | 15.9
| HCB | 0.7 | 17.5 | 81.8
| JPT | 0.0 | 15.9 | 84.1
| YRI | 4.8 | 39.5 | 55.8
| ASW | 14.0 | 40.4 | 45.6
| CHB | 0.7 | 17.5 | 81.8
| CHD | 0.9 | 13.8 | 85.3
| GIH | 11.9 | 55.4 | 32.7
| LWK | 10.9 | 53.6 | 35.5
| MEX | 3.4 | 50.0 | 46.6
| MKK | 16.0 | 39.7 | 44.2
| TSI | 36.3 | 46.1 | 17.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23666240
  |Trait=Testicular germ cell tumor
  |Title=Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.
  |RiskAllele=G
  |Pval=5E-8
  |OR=1.22
  |ORtxt=[1.11-1.34]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}